About Flore
Flore is a Healthcare company based in San Diego (United States) founded in 2016 by Suneer Sunny Jain. It operates as a customized probiotics for gut health are provided via stool analysis. Flore has raised $21.12 million across 6 funding rounds from investors including Human Longevity, Plug and Play Tech Center and Pangaea Ventures. The company has 16,436 employees. Its chief executive is Suneer Sunny Jain. Its website flore.com draws about 28 thousand monthly visits. Its Indian entity Sun Pharmaceutical Industries Limited reported revenue of ₹60,434 Cr. Its focus areas include Life Sciences, Nutraceuticals Tech, Dietary Supplements and Personalized. Its competitors include Viome, Evvy, Elo Health, uBiome and Ombre and 4 more; 8 of its 9 listed competitors have raised funding.
Company details
Flore was founded in 2016 in San Diego, United States, and operates in the health and wellness sector. Nutritional supplements focused on gut health are offered, including customized probiotics developed from stool sample analysis. These address issues such as bloating, gas, constipation, digestive problems, food tolerance, bowel regulation, and immune support. Services are delivered through personalized testing and product recommendations.
- Annual Revenue₹60,434 Cr
FY 2026 · +11% YoY
- Net Profit₹11,509 Cr
FY 2026 · 19% margin
- EBITDA₹18,340 Cr
FY 2026 · 30% margin
- Total Equity Funding$21.12M (USD)
in 6 rounds
- Latest Funding Round$9.25M (USD), Series A
Sep 2020
- InvestorsHuman Longevity
& 8 more
- Employee Count16,436
Associated legal entities of Flore
Flore operates through Sun Pharmaceutical Industries Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited Listed CIN L24230GJ1993PLC019050 | Active | 01 Mar 1993 | Vadodara, Gujarat | ₹60,434 Cr | 16,436 | 11 | View details |
Funding Insights of Flore
Flore has successfully raised a total of $21.12M across 6 strategic funding rounds. The most recent funding activity was a Series A round of $9.25 million completed in September 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $21.12M
- Total Rounds 6
- Last Round Series A — $9.25M
- First Round $250,000
(Jan 2018)
- Investors Count 9
All 6 funding rounds of Flore with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2020 | $9.25M | Series A | – | Pangaea Ventures, K3 Ventures | |
| Jun 2020 | $8.65M | Series A | – | Pangaea Ventures | |
| Dec 2018 | $2.97M | Seed | – | SOSV | – |
| Aug 2018 | $625,000 | Debt – Conventional | – | – | – |
| Jun 2018 | – | Seed | – | Plug and Play Tech Center | – |
| Jan 2018 | $250,000 | Seed | – | IndieBio | – |
9 investors in total: 9 institutional.
Investors in Flore
Flore has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Human Longevity, Plug and Play Tech Center and Pangaea Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment in hard tech for planetary health, focusing on materials science, chemistry, and biology. | – | pangaeaventures.com | - | |
Investments are made by K3 Ventures in early-stage technology startups. | – | k3ventures.com | Singapore, Singapore | |
Venture capital and accelerator services are provided across multiple sectors. | – | sosv.com | Cork, Ireland | |
Capital is provided to support biomedical industry innovations. | 2000 | etpvc.com | South San Francisco, USA | |
Food industry startups are funded by Danone Manifesto Ventures. | – | danoneventures.com | New York, United States | |
Startups are accelerated and invested in across multiple tech sectors. | 2006 | plugandplaytechcenter.com | Sunnyvale, United States | |
Biotech startups are accelerated through IndieBio's focused programs. | – | indiebio.co | San Francisco, United States | |
Funding for students is provided by The Orion Fund foundation. | – | theorionfund.org | Alameda, United States | |
Genomics data and cell therapy-based diagnostic and therapeutic solutions | 2013 | humanlongevity.com | San Diego, United States |
Investor details for Flore
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Sun Pharmaceutical Industries Limited (Flore)
Sun Pharmaceutical Industries Limited is the primary company behind Flore. The board of Sun Pharmaceutical Industries Limited currently have 9 directors; the longest-serving is Dilip Shantilal Shanghvi, appointed in 2008. 20 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Dilip Shantilal Shanghvi DIN 00005588 | Whole-time director | 01 Apr 2008 | 18 yrs 6 mo | Sun Pharmaceutical Industries Limited |
| Gautam Bhailal Doshi DIN 00004612 | Director | 25 May 2018 | 8 yrs 4 mo | Sun Pharmaceutical Industries Limited |
| Pawan Kumar Goenka DIN 00254502 | Director | 21 May 2021 | 5 yrs 5 mo | Sun Pharmaceutical Industries Limited |
| Aalok Dilip Shanghvi DIN 01951829 | Whole-time director | 01 Jun 2023 | 3 yrs 4 mo | Sun Pharmaceutical Industries Limited |
| Rolf Karl Heinz Hoffmann DIN 10200311 | Director | 15 Jun 2023 | 3 yrs 4 mo | Sun Pharmaceutical Industries Limited |
| Vidhi Dilip Shanghvi DIN 06497350 | Whole-time director | 22 May 2025 | 1 yr 5 mo | Sun Pharmaceutical Industries Limited |
| Kirti Wardhaman Ganorkar DIN 10620142 | Managing Director | 01 Sep 2025 | 1 yr 1 mo | Sun Pharmaceutical Industries Limited |
| Satyavati Berera DIN 05002709 | Director | 08 May 2026 | 5 mo | Sun Pharmaceutical Industries Limited |
| Andreas Eugen Busch DIN 11699735 | Director | 12 May 2026 | 5 mo | Sun Pharmaceutical Industries Limited |
People of Flore
2 people are tracked at Flore (2 in leadership); the tracked headcount is 16,436.
| Name | Role | Group |
|---|---|---|
Suneer Sunny Jain | Founder & CEO | Leadership |
Craig Rouskey | Chief Executive Officer | Leadership |
Complete people profiles for Flore
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Flore
Figures of Sun Pharmaceutical Industries Limited, the primary company behind Flore, for FY 2026. Revenue was ₹60,434 Cr (+11% year on year). Net profit was ₹11,509 Cr (19% margin). EBITDA was ₹18,340 Cr (30% margin). Revenue has grown at a compounded annual rate of +11% over three years and +12% over five years.
- ₹60,434 CrRevenue · FY 2026 · +11% YoY
- ₹11,509 CrNet profit · 19% margin
- ₹18,340 CrEBITDA · 30% margin
- ₹240 CrPaid-up capital
- 16,436Employees (provident fund records)
- +11%Revenue CAGR, 3 years
- +12%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Sun Pharmaceutical Industries Limited are on its company page.
Detailed financial statements for Flore
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Flore
3 dated milestones of Flore across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Flore is founded.
- Funding First funding round of $250K.
- Funding Latest funding round, Series A, of $9.2M.
Competitors of Flore
Flore has 9 listed competitors in our database, 8 of them funded. They include Viome, Evvy, Elo Health, uBiome and Ombre, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| viome.com | 2016 | Los Alamos, United States | $301.57M | 136 | Machine learning-based bioinformatics solutions for health insights are provided. | |
| evvy.com | 2002 | New York, United States | $19M | 9 | Vaginal microbiome test kits are provided through an online platform. | |
| elo.health | 2020 | San Francisco, United States | $18.49M | 11 | Personalized supplements are delivered based on biochemical analysis. | |
| ubiome.com | 2012 | San Francisco, United States | $109.62M | 33 | Provides comprehensive sequence datasets for human microbiome research and analysis. | |
| ombrelab.com | 2016 | San Francisco, United States | $5.3M | – | Microbiome-based personalized supplements are offered via gut testing kits. | |
| rootine.co | 2018 | Nashville, United States | $14.22M | – | Provider of personalized nutrition supplements | |
| jona.health | 2022 | Hialeah, United States | – | – | AI-powered microbiome profiling platform to improve digestive health | |
| wellnicity.com | 2002 | Austin, United States | $3.6M | – | Personalized diet and supplement recommendations are provided via genetic analysis. | |
| isplack.com | 2014 | Boulder, United States | $1.45M | – | Athlete-focused body care products are manufactured with science-backed formulations. |
Detailed competitors of Flore
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Flore
The website of Flore (flore.com) receives about 27.7K visits a month.
- Monthly visits27.7K
▼ 4.9% vs previous month
Websites whose visitors overlap most with Flore. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
nfcr.org | nfcr.org | 100% | – | #653,409 | – |
theprobioticsinstitute.com | theprobioticsinstitute.com | 66% | – | #2,698,690 | – |
biomprobiotics.com | biomprobiotics.com | 65% | – | #2,708,637 | – |
healthygut.com | healthygut.com | 65% | – | #674,082 | – |
| umzu.com | 62% | – | #288,177 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 20 similar websites and full traffic analytics for Flore
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 20 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Nutraceutical & Food-as-Medicine Platforms
10 companies that operate in the same segment as Flore (Nutraceutical & Food-as-Medicine Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Ayurvedic healthcare and nutritional products are provided by Kapiva. | 2016 | Bengaluru, Karnataka, India | USD 77.85 M | USD 27.35 M | 362 | |
Plant-based frozen meals are delivered via weekly subscriptions. | 2016 | London, England, United Kingdom | USD 69.9 M | USD 12.54 M | 146 | |
Therapies for metabolic health in chronic disease patients are provided. | 2014 | San Francisco, California, United States | USD 401.78 M | – | 910 | |
Nutritional supplements for multiple health ailments are developed. | 2005 | Mumbai, Maharashtra, India | USD 1.55 M | – | – | |
Personalized gut health solutions are provided by ZOE. | 2017 | New Castle, Pennsylvania, United States | USD 15 M | – | – | |
Machine learning-based bioinformatics solutions for health insights are provided. | 2016 | Los Alamos, New Mexico, United States | USD 301.57 M | – | – | |
Cellular health supplements for metabolic repair are developed and manufactured. | 2014 | New York, New York, United States | USD 66.1 M | – | – | |
Nutritional food and health supplements are provided by OZiva. | 2010 | Mumbai, Maharashtra, India | USD 17.32 M | USD 23.98 M | – | |
Low-carb products for weight loss are provided by Atkins. | 1960 | Denver, Colorado, United States | USD 15 M | – | – | |
Synbiotic supplements and fermented products for gut health are provided. | 2021 | Mumbai, Maharashtra, India | USD 20.02 M | USD 5.14 M | 88 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Flore
Complete news archive for Flore
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Flore
Flore was founded in 2016 and raised its 1st funding round 2 years after it was founded.
Flore is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Suneer Sunny Jain is the current CEO of Flore. They have also founded this company.
Flore is a funded company, having raised a total of $21.12M across 6 funding rounds to date. The company's 1st funding round was a Seed of $250K, raised on Jan 2018.
Flore has 16,436 employees.
The primary company behind Flore, Sun Pharmaceutical Industries Limited, reported revenue of ₹60,434 Cr for FY 2026, up 11% year on year.
Flore was founded in 2016 in San Diego, United States, and operates in the health and wellness sector. Nutritional supplements focused on gut health are offered, including customized probiotics developed from stool sample analysis. These address issues such as bloating, gas, constipation, digestive problems, food tolerance, bowel regulation, and immune support. Services are delivered through personalized testing and product recommendations.
Flore's top competitors include Viome, Evvy and Elo Health.
Flore has 9 investors. Key investors include Human Longevity, Plug and Play Tech Center, Pangaea Ventures, The Orion Fund, and K3 Ventures.
Flore operates through Sun Pharmaceutical Industries Limited.
The legal entities of Flore currently have 11 directors, including Pawan Kumar Goenka, Anoop Anjanikumar Deshpande, Dilip Shantilal Shanghvi and others.